Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 December 2022: Clinical Research  

Value of Early Laparoscopic Exploration for Primary Infertile Patients with Patent Fallopian Tubes Complicated with Pelvic Effusion

Jiexin Tang1ADE, Zhilin Wang1B, Danhua Lu1A, Yucen Xie2C, Dan Zhang13AEG*

DOI: 10.12659/MSM.938637

Med Sci Monit 2022; 28:e938637

0 Comments

Abstract

BACKGROUND: Endometriosis is a progressive disease, and early detection and early treatment are particularly important. The purpose of this study was to investigate the effect of the timing of laparoscopy on the spontaneous pregnancy rate of primary infertile patients complicated with pelvic effusion within 6 months after surgery.

MATERIAL AND METHODS: We enrolled 330 primary infertile patients with pelvic effusion and bilateral patent fallopian tubes. They were divided into 3 groups based on retrospective analysis of clinical data. Study Group 1 underwent laparoscopy 1 month after hysterosalpingography (HSG), Study Group 2 received laparoscopy after trying to conceive for 3 months, and the Control Group did not undergo laparoscopy. According to the specific conditions during laparoscopy, repair and plastic surgery of fallopian tube, electrocautery of endometriosis and uterine suspension were performed. The main observation indicators were proportions of retrograde menstruation, peritoneal endometriosis, and tubal adhesions in laparoscopy groups, and spontaneous pregnancy rates within 6 months.

RESULTS: The proportions of retrograde menstruation were 92.2% and 93.1% in Study Group 1 and Study Group 2, respectively, with no statistical significance. The proportions of peritoneal endometriosis were 51.0% and 64.7%, with a statistically significant difference. The proportions of tubal adhesions were 31.4% and 36.2%, with no statistical significance. The pregnancy rates within 6 months were 73.9%, 52.6%, and 13.1%, with a statistically significant difference for pairwise comparisons.

CONCLUSIONS: The pregnancy rate of primary infertile patients with patent fallopian tubes complicated with pelvic effusion can be significantly improved through early laparoscopic surgery (exploration and treatment).

Keywords: Endometriosis, Infertility, Laparoscopy, Pelvic Inflammatory Disease, Pregnancy, Ultrasonography, Doppler, Female, Humans, Fallopian Tubes, Fallopian Tube Diseases, Infertility, Female, Tissue Adhesions, Menstruation Disturbances

Background

Endometriosis (referred to as “EMs”) is a common sex hormone-dependent disease in which endometrial tissue (glands and stroma) grows and infiltrates outside the body of the uterus, subsequently causing pain and infertility. According to epidemiological surveys, the incidence of EMs in women of reproductive age is about 10% to 15%, and 30% to 50% of them are complicated with infertility [1], which seriously affects female reproductive function.

EMs includes peritoneal, ovarian, deeply infiltrative, and other types, of which peritoneal and ovarian types are the most common Ems [2]. Peritoneal EMs is a precursor (early) lesion of pelvic Ems [3]. Ovarian endometriosis cysts can be diagnosed by ultrasonography [4], but it is difficult to diagnose early EMs, that is, peritoneal EMs by ultrasonography [5]. In addition, the value of hysterosalpingography (HSG) for diagnosis of early EMs is limited because peritoneal EMs associated with only a few pelvic adhesions rarely cause lumen obstruction [6]. Therefore, minimally invasive, visualized laparoscopy has become the criterion standard method for diagnosing EMs, especially for early EMs [7]. Early diagnosis and treatment greatly improve the reproductive function of patients, since EMs is a common cause of infertility and a progressive disease. Accordingly, the purpose of this study was to investigate whether early laparoscopic exploration for primary infertile patients with pelvic effusion, fluid in the female pelvic cavity revealed by imaging examination [8], and patent fallopian tubes revealed by HSG is capable of detecting and eliminating pelvic EMs lesions and improving the pelvic microenvironment in the early stage, thereby increasing the postoperative pregnancy rate of patients.

Material and Methods

STUDY SUBJECTS:

The clinical data of primary infertile patients who visited the Department of Reproductive Endocrinology, West China Second University Hospital, Sichuan University from January 2017 to June 2021 were collected and screened retrospectively according to the following inclusion and exclusion criteria.

Inclusion criteria:

Exclusion criteria:

The sample size of this retrospective study was calculated by using the Power and Sample Size Calculations (version 3.1.6) on the basis of a previous study by Marcoux [9]. To attain statistical significance (α=0.05, power=80%), a minimum sample size of 60 subjects was required for each group.

According to our statistics, 1392 primary infertile patients had visited the outpatient department during the study period, among which 551 patients had pelvic effusion revealed by ultrasound examination, and the prevalence of pelvic effusion was 39.58% (551/1392). After consulting the relevant clinical data, 221 subjects were excluded from the study for the following reasons:

Finally, a total of 330 patients were included. The experimental protocol was established according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of West China Second University Hospital. Written informed consent was obtained from individuals or their guardians.

METHODS:

After strict screening, a total of 330 patients were included, and their clinical data were comprehensively collected for retrospective analysis. All had undergone HSG, the result of which revealed that the uterine cavity was normal with the bilateral fallopian tubes unobstructed. They were divided into 3 groups: Study Group 1 (153 cases), Study Group 2 (116 cases), and Control Group (61 cases), based on whether they underwent laparoscopic exploration and the timing of surgery. Patients in Study Group 1 underwent laparoscopic exploration 1 month after HSG, patients in Study Group 2 received laparoscopic exploration after trying to conceive for 3 months without fertilization after taking an HSG examination. According to the specific conditions during laparoscopy, repair and plastic surgery of fallopian tube, electrocautery of endometriosis and uterine suspension were performed. Patients in the Control Group, who refused surgery, only underwent expectant management or ovulation monitoring. Furthermore, for primary infertile patients with patent fallopian tubes complicated with pelvic effusion, we investigated the effects of diagnostic/therapeutic laparoscopy and the timing of surgery on the spontaneous pregnancy rate within 6 months after surgery.

GENERAL CONDITIONS:

The general conditions of all patients were recorded, including age, infertility duration, menstrual cycle, anti-Mullerian hormone (AMH), and body mass index (BMI).

LAPAROSCOPIC EXPLORATION:

The patients in the laparoscopic exploration groups (Study Group 1 and Study Group 2) underwent surgery under general anesthesia within 3 to 7 days after the end of 1 period, without sexual activity. The pelvic organs and peritoneal surface were comprehensively examined for EMs lesions to observe the distribution and characteristics of pelvic effusion, while the following operations were performed:

The surgical records were searched for relevant surgical data and compare the 2 groups of patients from:

COMPARISON OF SPONTANEOUS PREGNANCY RATES:

Patients in Study Group 1 and Study Group 2 were observed and expected to have spontaneous pregnancy for 6 months after surgery, and the patients in the Control Group were also observed for 6 months. Their pregnancy situation was determined by inquiring outpatient cases and telephone follow-up, and the spontaneous pregnancy rates within 6 months were compared among the 3 groups.

STATISTICS PROCESSING:

SPSS 26.0 software was used for statistical analysis of data, where quantitative data were expressed as (χ̆±s), with one-way analysis of variance used for comparisons among groups, and qualitative data were expressed as percentages (%) with the chi-square test used for comparisons among groups. Unless otherwise specified, the test level α was set at 0.05.

Results

COMPARISON OF GENERAL CONDITIONS OF PATIENTS IN THE 3 GROUPS:

The differences in the general information of the patients in the 3 groups, such as age, infertility duration, menstrual cycle, AMH level, and BMI, were not statistically significant (P>0.05), suggesting that the baseline data between the groups were comparable, as shown in Table 1.

COMPARISON OF SPONTANEOUS PREGNANCY AMONG THE 3 GROUPS OF PATIENTS:

Comparing spontaneous pregnancy rates within 6 months among the 3 groups, the ratios of Study Group 1, Study Group 2, and Control Group were 73.9%, 52.6%, and 13.1%, respectively, and the difference between groups was statistically significant (P<0.05) when using the Bonferroni adjustment method for pairwise comparison (Table 3). In our study, the reported spontaneous pregnancy rates after surgery were higher compared to other international studies, which may be related to the following factors:

COMPARISON OF PREGNANCY OUTCOMES AMONG THE 3 GROUPS OF PATIENTS:

The pregnancy outcomes of the 3 groups were recorded or tracked until miscarriage or delivery, and the pregnancy outcome indicators (abortion rate, live birth rate, and ectopic pregnancy rate) were compared. Among all the pregnant cases, the miscarriage rates of Study Group 1, Study Group 2, and Control Group were 15.0% (17/113), 19.7% (12/61), and 25.0% (2/8), respectively, and the live birth rates of the 3 groups were 85.0% (96/113), 80.3% (49/61), and 75.0% (6/8), respectively, with no statistically significant difference (P=0.646). The ectopic pregnancy rates of the 3 groups were 2.7% (3/113), 3.3% (2/61), and 12.5% (1/8), respectively. The ectopic pregnancy rate in the Control Group was obviously higher than that in the 2 study groups, but the difference was not statistically significant (P=0.381).

Discussion

PATHOGENESIS OF EMS – LED BY THE IMPLANTATION THEORY OF RETROGRADE MENSTRUATION:

The pathogenesis of EMs is not clearly understood and its occurrence may be related to various factors such as sex hormones, immunity, inflammation, and genetics. Sampson’s implantation theory of retrograde menstruation is currently the dominant theory. During menstruation, endometrial gland epithelial and stromal cells can flow backwards with menstrual blood, enter the pelvic cavity via the fallopian tubes, and be implanted in the ovary and the adjacent pelvic peritoneum for continuous growth and spreading, forming the pelvic EMs. In addition, the characteristics of the eutopic endometrium play a key role, that is, “eutopic endometrial determinism”, and the biological properties of the eutopic endometrium are the determinants of the development of EMs. Compared with non-EMs patients, the characteristics of eutopic endometrium of EMs patients, such as adhesion and invasiveness, have stronger ability to stimulate neovascularization. Other pathogenic mechanisms include coelomic metaplasia, vascular and lymphatic metastasis theory, and induction theory. According to the results of this study, for primary infertile patients with pelvic effusion and patent fallopian tubes revealed by B-mode ultrasound, more than 90% were found to have pelvic effusion retrograde menstrual blood during surgery (Figures 1–5). The proportion of patients with peritoneal EMs was 50%, which is much higher than the incidence of EMs (around 20%) reported in the literature. The possible reasons are that: 1) It is difficult to carry out early diagnosis for early EMs, which mainly includes peritoneal EMs through imaging such as ultrasound, which can easily lead to missed diagnosis. 2) The peritoneal EMs reported in this study was detected by laparoscopy, which overcomes the shortcomings of imaging, greatly improves the (early) diagnosis rate of EMs, and provides an objective basis for early treatment of EMs.

EFFECT OF EMS ON FERTILITY:

EMs is closely associated with infertility. According to epidemiological survey findings [11], there are currently about 176 million EMs patients in the world, and 20% to 50% of infertile women are complicated with EMs, which seriously affects the fertility of women of reproductive age. The concept of “EMs-associated infertility”, first introduced by Buyalos et al [12] in 2000, states that infertility and EMs are mutually influenced, where EMs may cause infertility or spontaneous abortion due to its influence on all aspects of pregnancy and, conversely, infertility is one of the risk factors for EMs.

The influencing mechanism of EMs on female fertility is complex and may cover the followings:

SIGNIFICANCE OF LAPAROSCOPIC SURGERY IN IMPROVING THE PREGNANCY RATE OF PATIENTS WITH EMS:

Laparoscopic exploration is a surgical diagnostic method commonly used for EMs. Laparoscopy allows exploration of lesion site and range and access to lesion tissue for histopathological diagnosis. According to the literature [22], laparoscopic removal of the endometrial lesion helps significantly improve the postoperative pregnancy rate of patients. The possible reason is that surgical removal of EMs lesions is accompanied by restoration of normal anatomical relationship of abdominopelvic cavity through separation of adhesions and flushing of abdominopelvic cavity with large amounts of normal saline to improve the fallopian tube function and ovarian ovulation function and the abdominopelvic microenvironment, thereby increasing the postoperative pregnancy rate.

SIGNIFICANCE OF EARLY LAPAROSCOPIC EXPLORATION FOR PRIMARY INFERTILE PATIENTS COMPLICATED WITH PELVIC EFFUSION:

EMs is a common disease in women of reproductive age and a common cause of infertility. EMs is a progressive disease with a rapid rate of progress. In the early stage, it mainly invades peritoneum (Figure 8), ovarian cortex, and uterosacral ligament, with a focal nature. As the disease develops, the lesions invade deeper and merge with each other, resulting in the formation of pelvic adhesions and chocolate cysts, eventually forming a “frozen pelvis”, which seriously affects the patient’s reproductive function and quality of life. Despite treatment, the pregnancy rate decreases, and relevant study findings have shown that the pregnancy rate of patients after treatment for old low-activity ectopic lesions (non-early stage) is significantly lower than that of the patients with fresh (early) active lesions [23]. Therefore, EMs should be diagnosed as early as possible for timely treatment to restore and improve fertility. However, imagological examination of early endometriosis lesions is mostly devoid of specific findings, and laparoscopic exploration has special significance as it provides a comprehensive understanding of a patient’s pelvic cavity under direct vision for early detection of punctate and flaky tissues and understanding of pelvic adhesions for early corresponding treatment. Removal of retrograde menstrual blood and flushing of the pelvic cavity with large amounts of normal saline during surgery also effectively improve the pelvic microenvironment and raise the pregnancy rate. The findings of this study also prove the viewpoints above that:

The literature [22] also indicates that laparoscopic resection of EMs lesions can improve the postoperative pregnancy rate of patients. The ASRM expert consensus [24,25] recommends that for patients with mild EMs at r-ASRM stage I–II, therapeutic laparoscopic surgery (resection or electrocautery of EMs lesions, and release of adhesions) is more effective than diagnostic laparoscopic surgery. Therapeutic laparoscopic surgery obeys the principle of “taking immediate treatment for lesions on sight”, that is, removing the lesions visible to the naked eye during surgery, and improving the abdominopelvic microenvironment and restoring the normal anatomical relationship by separating adhesions and flushing the abdominopelvic cavity with a large amount of normal saline, to improve the fallopian tube function and ovarian ovulation function, thereby increasing the postoperative pregnancy rate.

EMs is a progressive disease, and early detection and treatment is particularly important. According to our results, the prevalence of pelvic effusion in primary infertility patients was 39.58% (551/1392). After screening by consulting clinical data, the proportion of participants with only pelvic effusion was 23.71% (330/1392), which indicated the prevalence of “healthy” patients who would benefit from laparoscopy. For primary infertile patients with normal ovarian ovulation function and patent fallopian tubes complicated with pelvic effusion, the appropriate relaxation of laparoscopic surgery guidelines enables early removal of retrograde menstruation and early detection and treatment of pelvic EMs to improve the pelvic microenvironment for the purpose of the increasing pregnancy rate. The weaknesses of the study are as follows:

Conclusions

The pregnancy rate of primary infertile patients with patent fallopian tubes complicated with pelvic effusion can be significantly improved through early laparoscopic surgery (exploration and treatment). In the expectant treatment (non-surgery) group, the pregnancy rate is significantly lower than that in the laparoscopic surgery groups. Endometriosis is a progressive disease, and early detection and early treatment are particularly important. Moreover, the results of our study indicated that the pregnancy outcomes (abortion rate, live birth rate, and ectopic pregnancy rate) were not significantly different among the 3 groups. Theoretically, it is possible that there is a greater number of ectopic pregnancies in non-operatively managed patients with tubal adhesions. Therefore, to explore and analyze the effect of timing of laparoscopic surgery on pregnancy outcomes in primary infertile patients, we will consider expanding the sample size and conducting subgroup analysis (tubal adhesion group vs non-tubal adhesion group) in future research.

Figures

Bilateral patent fallopian tubes revealed by hysterosalpingography (the arrows mean diffusion of contrast medium). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 1. Bilateral patent fallopian tubes revealed by hysterosalpingography (the arrows mean diffusion of contrast medium). Image software: Adobe Photoshop, CS6, Adobe Systems. Pelvic effusion shown by transvaginal B-mode ultrasound (PE– pelvic effusion; UT – uterus). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 2. Pelvic effusion shown by transvaginal B-mode ultrasound (PE– pelvic effusion; UT – uterus). Image software: Adobe Photoshop, CS6, Adobe Systems. Retrograde menstrual blood revealed during laparoscopic surgery (the arrow means retrograde menstruation). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 3. Retrograde menstrual blood revealed during laparoscopic surgery (the arrow means retrograde menstruation). Image software: Adobe Photoshop, CS6, Adobe Systems. Left patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 4. Left patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems. Right patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 5. Right patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems. Adhesion of fallopian tube revealed during laparoscopy (the arrow means adhesion of fallopian tube). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 6. Adhesion of fallopian tube revealed during laparoscopy (the arrow means adhesion of fallopian tube). Image software: Adobe Photoshop, CS6, Adobe Systems. Fallopian tubes immersed in bloody peritoneal fluid (the arrows mean peritoneal defect, fallopian tube and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 7. Fallopian tubes immersed in bloody peritoneal fluid (the arrows mean peritoneal defect, fallopian tube and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems. Peritoneal endometriosis before laparoscopic electrocautery (the arrows mean endometriosis lesion and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 8. Peritoneal endometriosis before laparoscopic electrocautery (the arrows mean endometriosis lesion and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems. Peritoneal endometriosis after laparoscopic electrocautery. Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 9. Peritoneal endometriosis after laparoscopic electrocautery. Image software: Adobe Photoshop, CS6, Adobe Systems.

References

1. Vallerie A, Hsieh T, Baxi L, Peritoneal inclusion cyst: Effects on fertility and antepartum course: Obstet Gynecol, 2008; 112; 498-500

2. Olkowska-Truchanowicz J, Białoszewska A, Zwierzchowska A, Peritoneal fluid from patients with ovarian endometriosis displays immunosuppressive potential and stimulates Th2 response: Int J Mol Sci, 2021; 22(15); 8134

3. Anger D, Foster W, The link between environmental toxicant exposure and endometriosis: Front Biosci, 2008; 13; 1578-93

4. Johnson N, Hummelshoj L, Adamson G, World Endometriosis Society consensus on the classification of endometriosis: Hum Reprod, 2017; 32(2); 315-24

5. Practice Committee of the American Society for Reproductive Medicine, Endometriosis and infertility: A committee opinion: Fertil Steril, 2012; 98(3); 591-98

6. Niskar A, Needham L, Rubin C, Serum dioxins, polychlorinated biphenyls, and endometriosis: A case-control study in Atlanta: Chemosphere, 2009; 74(7); 944-49

7. Becker C, Bokor AMembers of the Endometriosis Guideline Core Group, ESHRE guideline: Endometriosis: Hum Reprod Open, 2022; 2022(2); hoac009

8. Davis JA, Gosink BB, Fluid in the female pelvis: Cyclic patterns: J Ultrasound Med, 1986; 5(2); 75-79

9. Marcoux S, Maheux R, Bérubé S, Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis: N Engl J Med, 1997; 337(4); 217-22

10. American Society for Reproductive Medicine, Revised American Society for Reproductive Medicine classification of endometriosis: 1996: Fertil Steril, 1997; 67(5); 817-21

11. Gallagher C, Mäkinen N, Harris H, Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis: Nat Commun, 2019; 10(1); 4857

12. Buyalos RP, Agarwal SK, Endometriosis-associated infertility: Curr Opin Obstet Gynecol, 2000; 12(5); 377-81

13. Broi M, Jordo-Jr AA, Rui AF, Navarro PA, Oocyte oxidative DNA damage may be involved in minimal/mild endometriosis-related infertility: Mol Reprod Dev, 2018; 85(2); 128-36

14. Bao H, Qu Q, Huang X, Impact of hydrosalpinx fluid on early human embryos: Syst Biol Reprod Med, 2017; 63(4); 279-84

15. Lebovic DI, Mueller MD, Taylor RN, Immunobiology of endometriosis: Fertil Steril, 2001; 75(1); 1-10

16. Cahill DJ, Hull MGR, Pituitary-ovarian dysfunction and endometriosis: Hum Reprod Update, 2000(1); 56-66

17. Doody MC, Gibbons WE, Zamah NM, Linear regression analysis of ultrasound follicular growth series: statistical relationship of growth rate and calculated date of growth onset to total growth period: Fertil Steril, 1987; 47(3); 436-40

18. Giudice LC, Kao LC, Endometriosis: Lancet, 2004; 364(9447); 1789-99

19. The Practice Committee of the American Society for Reproductive Medicine, Endometriosis and infertility: Fertil Steril, 2004; 86; S156-60

20. Wei Q, Clair J, Fu T, Stratton P, Nieman LK, Reduced expression of biomarkers associated with the implantation window in women with endometriosis: Fertil Steril, 2009; 91(5); 1686-91

21. Donaghay M, Lessey B, Uterine receptivity: Alterations associated with benign gynecological disease: Semin Reprod Med, 2007; 25(6); 461-75

22. Campo S, Campo V, Gambadauro P, Is a positive family history of endometriosis a risk factor for endometrioma recurrence after laparoscopic surgery?: Reprod Sci, 2014; 21(4); 526-31

23. Vimercati A, Achilarre M, Scardapane A, Accuracy of transvaginal sonography and contrast-enhanced magnetic resonance-colonography for the presurgical staging of deep infiltrating endometriosis: Ultrasound Obstet Gynecol, 2012; 40(5); 592-603

24. Saridogan E, ESHRE guideline: Management of women with endometriosis: Hum Reprod, 2014; 29(3); 400-12

25. Shi J, Dai Y, Zhang J, Pregnancy outcomes in women with infertility and coexisting endometriosis and adenomyosis after laparoscopic surgery: A long-term retrospective follow-up study: BMC Pregnancy Childbirth, 2021; 21(1); 383

Figures

Figure 1. Bilateral patent fallopian tubes revealed by hysterosalpingography (the arrows mean diffusion of contrast medium). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 2. Pelvic effusion shown by transvaginal B-mode ultrasound (PE– pelvic effusion; UT – uterus). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 3. Retrograde menstrual blood revealed during laparoscopic surgery (the arrow means retrograde menstruation). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 4. Left patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 5. Right patent fallopian tube revealed under laparoscopy (outflow of methylene blue solution). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 6. Adhesion of fallopian tube revealed during laparoscopy (the arrow means adhesion of fallopian tube). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 7. Fallopian tubes immersed in bloody peritoneal fluid (the arrows mean peritoneal defect, fallopian tube and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 8. Peritoneal endometriosis before laparoscopic electrocautery (the arrows mean endometriosis lesion and retrograde menstruation respectively). Image software: Adobe Photoshop, CS6, Adobe Systems.Figure 9. Peritoneal endometriosis after laparoscopic electrocautery. Image software: Adobe Photoshop, CS6, Adobe Systems.

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750